IBRX icon

ImmunityBio

131 hedge funds and large institutions have $125M invested in ImmunityBio in 2022 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 54 increasing their positions, 33 reducing their positions, and 31 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less ownership

Funds ownership:

less call options, than puts

Call options by funds: $ | Put options by funds: $

less funds holding

Funds holding:

37% less capital invested

Capital invested by funds: $200M → $125M (-$74.4M)

45% less first-time investments, than exits

New positions opened: 17 | Existing positions closed: 31

Holders
131
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$1.99M
Puts
$2.08M
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
1
$28M
2
$22M
3
$6.95M
4
$5.85M
5
$4.39M
6
$4.32M
7
$3.64M
8
$2.89M
9
$2.81M
10
$2.56M
11
$2.56M
12
$2.34M
13
$2.14M
14
$2.12M
15
$1.76M
16
$1.64M
17
$1.53M
18
$1.49M
19
$1.33M
20
$1.3M
21
$1.25M
22
$1.17M
23
$1.06M
24
$1.05M
25
$1.02M